Trevi Therapeutics director Michael Thomas Heffernan disposes of USD 595,329 in common shares

• Trevi Therapeutics director Michael Thomas Heffernan cut his direct common stock stake to 6,351 shares on Sep. 15, 2026.
• Disposed of 39,473 shares at USD 15.09 and USD 15.88 through option exercises and sales.
• Exercised options for 39,473 shares at USD 3.04 and USD 3.33.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trevi Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-394456), on September 17, 2026, and is solely responsible for the information contained therein.